10. Approval of issue of options to Directors in lieu of fees and for Dr Christian Behrenbruch for executive performance
To consider and, if thought fit, to pass the following resolutions as ordinary resolutions:
‘That, pursuant to section 208(1)(a) of the Corporations Act and Listing Rule 10.14, and in accordance with the Company’s Equity Option Plan, the members of the Company approve the granting of the following options:
(a) 300,000 options to Dr Cherrell Hirst, non-Executive Director and Interim Chairman in lieu of directors fees,
(b) 300,000 options to Mr Tim Hughes, non-Executive Director in lieu of directors fees, and
(c) 1,000,000 options to Dr Christian Behrenbruch, Executive Director in lieu of directors fees and executive performance, in the manner outlined in the Explanatory Memorandum.’
TIS Price at posting:
4.2¢ Sentiment: Buy Disclosure: Held
